New insights into the role of FGF-23 and Klotho in cardiovascular disease in chronic kidney disease patients.
Sign Up to like & getrecommendations! Published in 2020 at "Current vascular pharmacology"
DOI: 10.2174/1570161118666200420102100
Abstract: Alterations of fibroblast growth factor 23 (FGF-23) and Klotho levels are considered to be the earliest biochemical abnormality of chronic kidney disease - mineral and bone disease (CKD-MBD) syndrome. Moreover, emerging data suggests that the… read more here.
Keywords: role fgf; chronic kidney; disease; fgf klotho ... See more keywords